RNA Therapeutics and Vaccines Market to Soar USD 107.7 Billion by 2034 at Explosive 87% CAGR, Driven by Breakthrough RNA Technologies The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around USD 107.7 billion by 2034, rising at a 87% CAGR, a study […]
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company GlobeNewswire December 02, 2025 BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its fully human anti-IL-6 receptor (IL-6R) monoclonal antibody,
Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook GlobeNewswire December 02, 2025 VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and investor webinar. On November 26, 2025, Hydreight
Nano Labs Announces Annual General Meeting GlobeNewswire December 02, 2025 HONG KONG, Dec. 02, 2025 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that it will hold its 2025 Annual General Meeting of Shareholders (the “2025 Annual Meeting”)
New Crypto Mutuum Finance (MUTM) Reaches Critical Phase 6 Milestone With Less Than 5% Supply Remaining GlobeNewswire December 02, 2025 DUBAI, United Arab Emirates, Dec. 02, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project building a decentralized lending system, has reached a major milestone as Phase 6 of its presale drops below
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation GlobeNewswire December 02, 2025 Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a single 180mg dose of Briquilimab in the ETESIAN Study Preliminary data from ETESIAN
NevGold Intercepts Highest-Grade Oxide Antimony At Bullet Zone Discovery: 5.51% Antimony Over 4.6 Meters Within 4.00 g/t AuEq Over 41.1 Meters (0.96% Antimony And 0.29 g/t Au) at Limo Butte, Nevada GlobeNewswire December 02, 2025 Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company“) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased
Village Farms International Reaffirms its Commitment to the Texas Cannabis Industry GlobeNewswire December 02, 2025 Outcome of conditional license awards has zero impact on Company's financial performance, outlook or strategy Company believes that its operating capabilities and infrastructure are well suited to support a viable industry in Texas MARFA, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE)
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer GlobeNewswire December 02, 2025 NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, today announced the appointment of Petra Kaufmann, M.D., M.S., F.A.A.N., as Chief Medical Officer.
Next Hydrogen Solutions Inc. Announces Change of Auditor GlobeNewswire December 02, 2025 MISSISSAUGA, Ontario, Dec. 02, 2025 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (TSXV: NXH, OTC: NXHSF) (“Next Hydrogen” or the “Company“), announces that it has changed its auditor from KPMG LLP (“Former Auditor“) to MNP LLP (“Successor Auditor“). The Former Auditor resigned at